have been reading re the delivery device OSL has for treatment of pancreatic cancer. Seems to be quite a simple process to administer - by injection. Not a drug, a device, so testing is more streamlined than if a drug. There are parallels to SRX here, if what I'm reading is correct, though SRX is clearly far more advanced. Still - look at the mini market cap here. Interesting stock
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.000(0.00%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.24 | $1.19 | $50.03K | 41.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14241 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 3333 | 1 |
View Market Depth
| Last trade - 11.29am 01/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |